Repeated transarterial chemoembolization: An overfitting effort?

Retreatment with TACE: The ABCR SCORE, an aid to the decision-making processJournal of HepatologyVol. 62Issue 4PreviewTransarterial chemoembolization (TACE) is the standard of care for intermediate stage hepatocellular carcinoma (HCC) and it is the most commonly used treatment for HCC worldwide. However, no prognostic indices, designed to select appropriate candidates for repeat conventional TACE, have been incorporated in the guidelines....